The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam Feuerstein writes.
The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...
Pfizer CEO Dr. Albert Bourla was loudly booed during a White House Black History Month event where he was introduced by President Trump.
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.
The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...
Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.
Greek-American Pfizer CEO Dr Albert Bourla faced an unwelcoming reception at the White House during an event celebrating ...
Dividend payers are solid performers. One reason is that a company has to reach a point where it has some fairly dependable ...
Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even more things you need to think about. I’m David Westin, and this week we heard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results